Christopher Volker insider trades
Open-market stock purchases and sales by Christopher Volker, Chief Financial Officer at NEUROONE MEDICAL TECHNOLOGIES Corp, from SEC Form 4 filings since Nov 10, 2023.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +13%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 28, 2026 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Bought (not open market) | — |
Companies traded
- NMTC NEUROONE MEDICAL TECHNOLOGIES Corp: 1 buy, last Aug 28, 2026